Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke

ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted f...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria Vol. 76; no. 1; pp. 22 - 25
Main Authors: Monteiro, Jean M.C., San-Martin, Daniel L., Silva, Beatriz C.G., Jesus, Pedro A.P. de, Oliveira, Jamary
Format: Journal Article
Language:English
Published: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil Thieme Revinter Publicações Ltda 01-01-2018
Academia Brasileira de Neurologia - ABNEURO
Academia Brasileira de Neurologia (ABNEURO)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted from January 2011 to December 2014. Results Forty-two patients with Chagas disease who were using anticoagulation were studied (age 62.9±12.4 years), 59.5% female and 47.6% with previous CIS, 78.6% with non-valvular atrial fibrillation and 69.7% with dilated cardiomyopathy. Warfarin was used in 78.6% of patients and dabigatran (at different times) in 38%. In the warfarin group, those with CIS had more medical appointments per person-years of follow-up (11.7 vs 7.9), a higher proportion of international normalized ratios within the therapeutic range (57% vs 42% medical appointments, p = 0.025) and an eight times higher frequency of minor bleeding (0.64 vs 0.07 medical appointments). Conclusion Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding.
AbstractList ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted from January 2011 to December 2014. Results Forty-two patients with Chagas disease who were using anticoagulation were studied (age 62.9±12.4 years), 59.5% female and 47.6% with previous CIS, 78.6% with non-valvular atrial fibrillation and 69.7% with dilated cardiomyopathy. Warfarin was used in 78.6% of patients and dabigatran (at different times) in 38%. In the warfarin group, those with CIS had more medical appointments per person-years of follow-up (11.7 vs 7.9), a higher proportion of international normalized ratios within the therapeutic range (57% vs 42% medical appointments, p = 0.025) and an eight times higher frequency of minor bleeding (0.64 vs 0.07 medical appointments). Conclusion Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding. RESUMO Objetivos descrever as características da anticoagulação em pacientes com manifestações cardíacas da doença de Chagas (MCDC) e comparar os participantes com sem acidente vascular cerebral isquêmico cardioembólico (AVCIC). Resultados 42 pacientes com MCDC em anticoagulação foram estudados (62,9 ± 12,4 anos), 59,5% do sexo feminino e 47,6% com AVCIC prévio, 78,6% portadores de fibrilação atrial não valvar e 69,7% com cardiomiopatia dilatada. Varfarina foi utilizada em 78,6% dos pacientes e dabigatrana em 38% (em momentos diferentes). No grupo da varfarina, aqueles com AVCIC tiveram mais consultas médicas por pessoas-ano de seguimento (11,7 vs 7,9), maior taxa de RNI na faixa terapêutica (57% vs 42% consultas médicas, p = 0,025) e uma frequência oito vezes maior de sangramento menor (0,64 vs. 0,07 consultas médicas). Conclusão pacientes com MCDC e AVCIC prévio têm melhor controle de RNI com maior frequência de sangramento menor.
ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted from January 2011 to December 2014. Results Forty-two patients with Chagas disease who were using anticoagulation were studied (age 62.9±12.4 years), 59.5% female and 47.6% with previous CIS, 78.6% with non-valvular atrial fibrillation and 69.7% with dilated cardiomyopathy. Warfarin was used in 78.6% of patients and dabigatran (at different times) in 38%. In the warfarin group, those with CIS had more medical appointments per person-years of follow-up (11.7 vs 7.9), a higher proportion of international normalized ratios within the therapeutic range (57% vs 42% medical appointments, p = 0.025) and an eight times higher frequency of minor bleeding (0.64 vs 0.07 medical appointments). Conclusion Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding.
To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted from January 2011 to December 2014. Forty-two patients with Chagas disease who were using anticoagulation were studied (age 62.9±12.4 years), 59.5% female and 47.6% with previous CIS, 78.6% with non-valvular atrial fibrillation and 69.7% with dilated cardiomyopathy. Warfarin was used in 78.6% of patients and dabigatran (at different times) in 38%. In the warfarin group, those with CIS had more medical appointments per person-years of follow-up (11.7 vs 7.9), a higher proportion of international normalized ratios within the therapeutic range (57% vs 42% medical appointments, p = 0.025) and an eight times higher frequency of minor bleeding (0.64 vs 0.07 medical appointments). Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding.
ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic ischemic stroke (CIS). Methods A retrospective cohort of patients with Chagas disease, using anticoagulation, conducted from January 2011 to December 2014. Results Forty-two patients with Chagas disease who were using anticoagulation were studied (age 62.9±12.4 years), 59.5% female and 47.6% with previous CIS, 78.6% with non-valvular atrial fibrillation and 69.7% with dilated cardiomyopathy. Warfarin was used in 78.6% of patients and dabigatran (at different times) in 38%. In the warfarin group, those with CIS had more medical appointments per person-years of follow-up (11.7 vs 7.9), a higher proportion of international normalized ratios within the therapeutic range (57% vs 42% medical appointments, p = 0.025) and an eight times higher frequency of minor bleeding (0.64 vs 0.07 medical appointments). Conclusion Patients with Chagas disease and previous CIS had better control of INR with a higher frequency of minor bleeding.
Abstract_FL RESUMO Objetivos descrever as características da anticoagulação em pacientes com manifestações cardíacas da doença de Chagas (MCDC) e comparar os participantes com sem acidente vascular cerebral isquêmico cardioembólico (AVC IC ). Resultados 42 pacientes com MCDC em anticoagulação foram estudados (62,9 ± 12,4 anos), 59,5% do sexo feminino e 47,6% com AVC IC prévio, 78,6% portadores de fibrilação atrial não valvar e 69,7% com cardiomiopatia dilatada. Varfarina foi utilizada em 78,6% dos pacientes e dabigatrana em 38% (em momentos diferentes). No grupo da varfarina, aqueles com AVC IC tiveram mais consultas médicas por pessoas-ano de seguimento (11,7 vs 7,9), maior taxa de RNI na faixa terapêutica (57% vs 42% consultas médicas, p = 0,025) e uma frequência oito vezes maior de sangramento menor (0,64 vs. 0,07 consultas médicas). Conclusão pacientes com MCDC e AVC IC prévio têm melhor controle de RNI com maior frequência de sangramento menor.
Author Oliveira, Jamary
Monteiro, Jean M.C.
Silva, Beatriz C.G.
Jesus, Pedro A.P. de
San-Martin, Daniel L.
AuthorAffiliation Universidade Federal da Bahia
AuthorAffiliation_xml – name: Universidade Federal da Bahia
Author_xml – sequence: 1
  givenname: Jean M.C.
  surname: Monteiro
  fullname: Monteiro, Jean M.C.
  organization: Universidade Federal da Bahia, Faculdade de Medicina, Salvador BA, Brasil
– sequence: 2
  givenname: Daniel L.
  surname: San-Martin
  fullname: San-Martin, Daniel L.
  organization: Universidade Federal da Bahia, Faculdade de Medicina, Salvador BA, Brasil
– sequence: 3
  givenname: Beatriz C.G.
  surname: Silva
  fullname: Silva, Beatriz C.G.
  organization: Universidade Federal da Bahia, Faculdade de Medicina, Salvador BA, Brasil
– sequence: 4
  givenname: Pedro A.P. de
  surname: Jesus
  fullname: Jesus, Pedro A.P. de
  organization: Universidade Federal da Bahia, Complexo Hospitalar Professor Edgard Santos, Salvador BA, Brasil
– sequence: 5
  givenname: Jamary
  surname: Oliveira
  fullname: Oliveira, Jamary
  organization: Universidade Federal da Bahia, Complexo Hospitalar Professor Edgard Santos, Salvador BA, Brasil
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29364390$$D View this record in MEDLINE/PubMed
BookMark eNpdUk1vEzEUtFARTQs_gAvaI5ctzx_74WMVQVupEgdA4mZ57efE6a4d1rsq_HucbhIkTn62Z8bz5vmKXIQYkJD3FG5oJeETAIiStewnA9oAbeEVWdG6aUvBWHNBVuf7S3KV0g6ACSmbN-SSSV4LLmFFnm7D5E3Um7nXk4-h8KHY5wrDlIpnP20Lo0frtSkGHbzDNL3AUhFdsd7qjU6F9Ql1wkIHu4AjDl3svSl8MlsccpGmMT7hW_La6T7hu-N6TX58-fx9fV8-fr17WN8-lkZImEpnJZrcEXBmedPZmlYMaqGNo01njBUOnDTOdh1rXVdzARVi4xygk5wbw6_Jw6Jro96p_egHPf5RUXv1chDHjdJj7rpHZazpaCN5i84K06HkTYvWCM4bS3N8Wetm0UrGYx_VLs5jyObVt0O46hh-mzcHOGOZ8HEh7Mf4a855qSHHgH2vA8Y5KSoltFUF8qBNF6gZY0ojurNXCuowYHV64_dpwJnz4Sg_dwPaM-M00QyABTBtPQ74z_D_mudPw_8C_m6wsQ
CitedBy_id crossref_primary_10_1590_0074_02760210172
crossref_primary_10_1590_0004_282x20180152
crossref_primary_10_1097_WCO_0000000000000641
crossref_primary_10_1097_DCC_0000000000000590
crossref_primary_10_1097_WCO_0000000000000919
Cites_doi 10.1056/NEJMoa1300615
10.1007/s00228-012-1411-6
10.1161/01.STR.0000163104.92943.50
10.1161/STROKEAHA.109.560854
10.1136/jnnp.74.4.516
10.1161/01.STR.0000208294.46968.a4
10.1161/01.STR.0000177866.13451.e4
10.1159/000069893
10.1056/NEJMra1410150
10.1056/NEJMoa0905561
10.1161/CIRCULATIONAHA.106.653048
10.1016/j.jns.2008.12.015
10.1161/STROKEAHA.113.000990
ContentType Journal Article
Copyright Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright_xml – notice: Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon.
– notice: This work is licensed under a Creative Commons Attribution 4.0 International License.
DBID 0U6
NPM
AAYXX
CITATION
7X8
GPN
DOA
DOI 10.1590/0004-282X20170180
DatabaseName Thieme Connect Journals Open Access
PubMed
CrossRef
MEDLINE - Academic
SciELO
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef


PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Anticoagulação nas manifestações cardíacas da doença de Chagas e acidente vascular cerebral isquêmico cardioembólico
DocumentTitle_FL Anticoagulação nas manifestações cardíacas da doença de Chagas e acidente vascular cerebral isquêmico cardioembólico
EISSN 1678-4227
EndPage 25
ExternalDocumentID oai_doaj_org_article_cdcb17938efd4cbe9378edc4337d1000
S0004_282X2018000100022
10_1590_0004_282x20170180
29364390
10_1590_0004_282X20170180
Genre Journal Article
GroupedDBID ---
.GJ
0R~
0U6
23N
2WC
53G
5GY
5VS
6J9
ABIVO
ABXHO
ADBBV
AENEX
AHRAW
ALMA_UNASSIGNED_HOLDINGS
APOWU
AZFZN
BAWUL
BCNDV
C1A
CS3
DIK
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
IPNFZ
KQ8
KWQ
M~E
OK1
P2P
PGMZT
RIG
RNS
RPM
RSC
RTC
SCD
XSB
NPM
AAYXX
CITATION
7X8
GPN
ID FETCH-LOGICAL-c490t-fd9ec201032d37bd6152064acf17bccd4f0f9cfdbb28fb63405ee7ff0ef933cc3
IEDL.DBID DOA
ISSN 0004-282X
1678-4227
IngestDate Tue Oct 22 15:16:16 EDT 2024
Tue Nov 19 22:12:01 EST 2024
Fri Oct 25 00:06:23 EDT 2024
Thu Nov 21 20:46:27 EST 2024
Wed Oct 16 00:58:47 EDT 2024
Sun Nov 24 15:08:19 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords acidente vascular cerebral
atrial fibrillation
varfarina
Chagas disease
doença de Chagas
fibrilação atrial
stroke
warfarin
Language English
License CC BY-NC-ND 4.0
This work is licensed under a Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c490t-fd9ec201032d37bd6152064acf17bccd4f0f9cfdbb28fb63405ee7ff0ef933cc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/cdcb17938efd4cbe9378edc4337d1000
PMID 29364390
PQID 1990855090
PQPubID 23479
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_cdcb17938efd4cbe9378edc4337d1000
scielo_journals_S0004_282X2018000100022
proquest_miscellaneous_1990855090
crossref_primary_10_1590_0004_282x20170180
pubmed_primary_29364390
thieme_journals_10_1590_0004_282X20170180
PublicationCentury 2000
PublicationDate 20180100
2018-Jan
2018-01-00
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 20180100
PublicationDecade 2010
PublicationPlace Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
PublicationPlace_xml – name: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
– name: Brazil
PublicationTitle Arquivos de neuro-psiquiatria
PublicationTitleAlternate Arq Neuropsiquiatr
PublicationYear 2018
Publisher Thieme Revinter Publicações Ltda
Academia Brasileira de Neurologia - ABNEURO
Academia Brasileira de Neurologia (ABNEURO)
Publisher_xml – name: Thieme Revinter Publicações Ltda
– name: Academia Brasileira de Neurologia - ABNEURO
– name: Academia Brasileira de Neurologia (ABNEURO)
References Paixão LC (ref7) 2009; 40
Mansur AP (ref2) 2003; 22
Oliveira Filho J (ref5) 2005; 36
Eikelboom JW (ref14) 2013; 369
Sousa AS (ref9) 2008; 91
Hori M (ref13) 2013; 44
Connolly SJ (ref12) 2009; 361
Carod-Artal FJ (ref4) 2003; 74
Nunes MCP (ref8) 2009; 278
Martins MA (ref15) 2013; 69
Carod-Artal FJ (ref6) 2005; 36
Birman-Deych E (ref10) 2006; 37
Hylek EM (ref11) 2007; 115
(ref1) 2002; 905
Longo DL (ref3) 2015; 373
Nunes, MCP; Barbosa, MM; Ribeiro, ALP; Barbosa, FB; Rocha, MO 2009; 278
Martins, MA; Ribeiro, DD; Nobre, VA; Pereira, FR; César, CC; Rocha, MO 2013; 69
Paixão, LC; Ribeiro, AL; Valacio, RA; Teixeira, AL 2009; 40
Birman-Deych, E; Radford, MJ; Nilasena, DS; Gage, BF 2006; 37
Longo, DL 2015; 373
Hylek, EM; Evans-Molina, C; Shea, C; Henault, LE; Regan, S 2007; 115
Sousa, AS; Xavier, SS; Freitas, GR; Hasslocher-Moreno, A 2008; 91
Eikelboom, JW; Connolly, SJ; Brueckmann, M; Granger, CB; Kappetein, AP; Mack, MJ 2013; 369
Mansur, AP; Souza, MFM; Favarato, D; Avakian, SD; César, LAM; Aldiqui, JM; Ramirs, JAF 2003; 22
Connolly, SJ; Ezekowitz, MD; Yusuf, S; Eikelboom, J; Oldgren, J; Parekh, A 2009; 361
Carod-Artal, FJ; Vargas, AP; Melo, M; Horan, TA 2003; 74
Carod-Artal, FJ; Vargas, AP; Horan, TA; Nunes, LGN 2005; 36
Hori, M; Connolly, SJ; Zhu, J; Liu, LS; Lau, CP; Pais, P 2013; 44
Oliveira Filho, J; Viana, LC; Vieira-de-Melo, R; Faiçal, F; Torreão, JA; Villar, FA 2005; 36
2002; 905
References_xml – volume: 91
  start-page: 306
  issue: 5
  year: 2008
  ident: ref9
  article-title: Prevention strategies of cardioembolic ischemic stroke in Chagas’ disease
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Sousa AS
– volume: 369
  start-page: 1206
  issue: 13
  year: 2013
  ident: ref14
  article-title: Dabigatran versus Warfarin in patients with mechanical heart valves
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1300615
  contributor:
    fullname: Eikelboom JW
– volume: 69
  start-page: 919
  issue: 4
  year: 2013
  ident: ref15
  article-title: Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosomacruzi infection
  publication-title: Eur J Clin Pharmacol
  doi: 10.1007/s00228-012-1411-6
  contributor:
    fullname: Martins MA
– volume: 36
  start-page: 965
  issue: 5
  year: 2005
  ident: ref6
  article-title: Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease
  publication-title: Stroke
  doi: 10.1161/01.STR.0000163104.92943.50
  contributor:
    fullname: Carod-Artal FJ
– volume: 905
  start-page: 1
  year: 2002
  ident: ref1
  article-title: Control of Chagas’ disease: report of a WHO Expert Committee
  publication-title: World Health Organ Tech Rep Ser
– volume: 40
  start-page: 3691
  issue: 12
  year: 2009
  ident: ref7
  article-title: Chagas disease: independent risk factor for stroke
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.109.560854
  contributor:
    fullname: Paixão LC
– volume: 74
  start-page: 516
  issue: 4
  year: 2003
  ident: ref4
  article-title: American trypanosomiasis (Chagas’ disease): an unrecognised cause of stroke
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.74.4.516
  contributor:
    fullname: Carod-Artal FJ
– volume: 37
  start-page: 1070
  issue: 4
  year: 2006
  ident: ref10
  article-title: Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation
  publication-title: Stroke
  doi: 10.1161/01.STR.0000208294.46968.a4
  contributor:
    fullname: Birman-Deych E
– volume: 36
  start-page: 2015
  issue: 9
  year: 2005
  ident: ref5
  article-title: Chagas disease Is an independent risk factor for stroke baseline characteristics of a Chagas disease cohort
  publication-title: Stroke
  doi: 10.1161/01.STR.0000177866.13451.e4
  contributor:
    fullname: Oliveira Filho J
– volume: 22
  start-page: 179
  issue: 3
  year: 2003
  ident: ref2
  article-title: Stroke and ischemic heart disease mortality trends in Brazil from 1979 to 1996
  publication-title: Neuroepidemiology
  doi: 10.1159/000069893
  contributor:
    fullname: Mansur AP
– volume: 373
  start-page: 456
  issue: 5
  year: 2015
  ident: ref3
  article-title: Chagas’ fisease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1410150
  contributor:
    fullname: Longo DL
– volume: 361
  start-page: 1139
  issue: 12
  year: 2009
  ident: ref12
  article-title: Dabigatran versus Warfarin in Patients with Atrial Fibrillation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0905561
  contributor:
    fullname: Connolly SJ
– volume: 115
  start-page: 2689
  issue: 21
  year: 2007
  ident: ref11
  article-title: Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.653048
  contributor:
    fullname: Hylek EM
– volume: 278
  start-page: 96
  issue: 1-2
  year: 2009
  ident: ref8
  article-title: Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study
  publication-title: Journal of the Neurological Sciences
  doi: 10.1016/j.jns.2008.12.015
  contributor:
    fullname: Nunes MCP
– volume: 44
  start-page: 1891
  issue: 7
  year: 2013
  ident: ref13
  article-title: Dabigatran versus Warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and Non-Asians with atrial fibrillation
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.113.000990
  contributor:
    fullname: Hori M
– volume: 36
  start-page: 2015
  issue: 9
  year: 2005
  end-page: 2017
  article-title: Chagas disease Is an independent risk factor for stroke baseline characteristics of a Chagas disease cohort
  publication-title: Stroke
  contributor:
    fullname: Oliveira Filho, J; Viana, LC; Vieira-de-Melo, R; Faiçal, F; Torreão, JA; Villar, FA
– volume: 91
  start-page: 306
  issue: 5
  year: 2008
  end-page: 310
  article-title: Prevention strategies of cardioembolic ischemic stroke in Chagas’ disease
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Sousa, AS; Xavier, SS; Freitas, GR; Hasslocher-Moreno, A
– volume: 37
  start-page: 1070
  issue: 4
  year: 2006
  end-page: 1074
  article-title: Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation
  publication-title: Stroke
  contributor:
    fullname: Birman-Deych, E; Radford, MJ; Nilasena, DS; Gage, BF
– volume: 373
  start-page: 456
  issue: 5
  year: 2015
  end-page: 466
  article-title: Chagas’ fisease
  publication-title: N Engl J Med
  contributor:
    fullname: Longo, DL
– volume: 361
  start-page: 1139
  issue: 12
  year: 2009
  end-page: 1151
  article-title: Dabigatran versus Warfarin in Patients with Atrial Fibrillation
  publication-title: N Engl J Med
  contributor:
    fullname: Connolly, SJ; Ezekowitz, MD; Yusuf, S; Eikelboom, J; Oldgren, J; Parekh, A
– volume: 115
  start-page: 2689
  issue: 21
  year: 2007
  end-page: 2696
  article-title: Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
  publication-title: Circulation
  contributor:
    fullname: Hylek, EM; Evans-Molina, C; Shea, C; Henault, LE; Regan, S
– volume: 69
  start-page: 919
  issue: 4
  year: 2013
  end-page: 928
  article-title: Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosomacruzi infection
  publication-title: Eur J Clin Pharmacol
  contributor:
    fullname: Martins, MA; Ribeiro, DD; Nobre, VA; Pereira, FR; César, CC; Rocha, MO
– volume: 905
  start-page: 1
  year: 2002
  end-page: 92
  article-title: Control of Chagas’ disease: report of a WHO Expert Committee
  publication-title: World Health Organ Tech Rep Ser
– volume: 36
  start-page: 965
  issue: 5
  year: 2005
  end-page: 970
  article-title: Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease
  publication-title: Stroke
  contributor:
    fullname: Carod-Artal, FJ; Vargas, AP; Horan, TA; Nunes, LGN
– volume: 40
  start-page: 3691
  issue: 12
  year: 2009
  end-page: 3694
  article-title: Chagas disease: independent risk factor for stroke
  publication-title: Stroke
  contributor:
    fullname: Paixão, LC; Ribeiro, AL; Valacio, RA; Teixeira, AL
– volume: 278
  start-page: 96
  issue: 1-2
  year: 2009
  end-page: 101
  article-title: Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study
  publication-title: Journal of the Neurological Sciences
  contributor:
    fullname: Nunes, MCP; Barbosa, MM; Ribeiro, ALP; Barbosa, FB; Rocha, MO
– volume: 44
  start-page: 1891
  issue: 7
  year: 2013
  end-page: 1896
  article-title: Dabigatran versus Warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and Non-Asians with atrial fibrillation
  publication-title: Stroke
  contributor:
    fullname: Hori, M; Connolly, SJ; Zhu, J; Liu, LS; Lau, CP; Pais, P
– volume: 22
  start-page: 179
  issue: 3
  year: 2003
  end-page: 183
  article-title: Stroke and ischemic heart disease mortality trends in Brazil from 1979 to 1996
  publication-title: Neuroepidemiology
  contributor:
    fullname: Mansur, AP; Souza, MFM; Favarato, D; Avakian, SD; César, LAM; Aldiqui, JM; Ramirs, JAF
– volume: 369
  start-page: 1206
  issue: 13
  year: 2013
  end-page: 1214
  article-title: Dabigatran versus Warfarin in patients with mechanical heart valves
  publication-title: N Engl J Med
  contributor:
    fullname: Eikelboom, JW; Connolly, SJ; Brueckmann, M; Granger, CB; Kappetein, AP; Mack, MJ
– volume: 74
  start-page: 516
  issue: 4
  year: 2003
  end-page: 518
  article-title: American trypanosomiasis (Chagas’ disease): an unrecognised cause of stroke
  publication-title: J Neurol Neurosurg Psychiatry
  contributor:
    fullname: Carod-Artal, FJ; Vargas, AP; Melo, M; Horan, TA
SSID ssj0024997
Score 2.2020566
Snippet ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and...
To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and without cardioembolic...
ABSTRACT Objectives To describe anticoagulation characteristics in patients with cardiac complications from Chagas disease and compare participants with and...
SourceID doaj
scielo
proquest
crossref
pubmed
thieme
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 22
SubjectTerms atrial fibrillation
Chagas disease
NEUROSCIENCES
PSYCHIATRY
stroke
warfarin
Title Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke
URI http://dx.doi.org/10.1590/0004-282X20170180
https://www.ncbi.nlm.nih.gov/pubmed/29364390
https://search.proquest.com/docview/1990855090
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000100022&lng=en&tlng=en
https://doaj.org/article/cdcb17938efd4cbe9378edc4337d1000
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_agzfx2ydWIgiiENyXZD9yrLWlF71U4d1CPibto3a3dN8D__zObLLPhwhevC2bgU0yk8xvMtnfMPYuKuN1UFp0oJXQ6ENEZ-paKN0knxCSOkfnHWfn7bdV9-WEaHJ2pb7oTlimB84T9ynE4MmIOkhRBw_oTjuIQSvVRjqbnnbfqpmDqZllz-SyKrgVCy1lW_KZtano1wUtMND4JYk6Zkl8kHseaSLu_xvaJCpRXG0_B3zYXK7hGvb80Okj9rAASH6UO_6Y3YP-CXvwtaTIn7Krox5bBndR6nLxdc8LeerI6dSVh8koAifmiwRjzsWPfEj8-NJduJGXpA13fczCA1x74g_ma4yF6TY9Hze3wxU8Yz9OT74fn4lSUUEEbaqNSNFAoPy3klG1PiKckYhJXEjL1ocQdaqSCSl6L7vkG4VoDqBNqYJklApBPWcH_dDDS8YlQjvlwzIBAkjwqavqGqqmkqC9a3xasI_zrNqbTJxhKeBAFVDCW9t9FSzYZ5r3nSBxXk8v0BJssQT7L0tYsLez1iyuEUp8uB6G7WiX6HKJuM2gzIuszt2nEO4QKMOW91m_tizi0Z7P_VxJ6iSFzwR5FuxDNoDfkn8ObDUP7NX_GNhrdrC53cIhuz_G7ZvJ0O8ABTb-gA
link.rule.ids 230,315,782,786,866,887,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anticoagulation+in+patients+with+cardiac+manifestations+of+Chagas+disease+and+cardioembolic+ischemic+stroke&rft.jtitle=Arquivos+de+neuro-psiquiatria&rft.au=Monteiro%2C+Jean+M+C&rft.au=San-Martin%2C+Daniel+L&rft.au=Silva%2C+Beatriz+C+G&rft.au=Jesus%2C+Pedro+A+P+de&rft.date=2018-01-01&rft.eissn=1678-4227&rft.volume=76&rft.issue=1&rft.spage=22&rft.epage=25&rft_id=info:doi/10.1590%2F0004-282X20170180&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-282X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-282X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-282X&client=summon